Effect of EECP on Anterior Ischemic Optic Neuropathy — AION

Anterior Ischemic Optic Neuropathy Clinical Trial

Official title:
Study of the Effect of EECP on Anterior Ischemic Optic Neuropathy

Status Recruiting

Clinical Trial Summary

Enhanced External Counterpulsation(EECP) therapy may promote the recovery of visual function by improving the blood perfusion of eyes. The present study aims to investigate the effect of EECP on Anterior Ischemic Optic Neuropathy.

Clinical Trial Description

Patients with Anterior Ischemic Optic Neuropathy are randomized into two groups: one group receive standard medical treatment for ischemic optic neuropathy, the other group plus EECP therapy besides standard medical treatment. ;

Study Design

Related Conditions & MeSH terms

Anterior Ischemic Optic Neuropathy
Ischemia
Optic Nerve Diseases
Optic Neuropathy, Ischemic
Peripheral Nervous System Diseases

Clinical Trial Details

NCT number	NCT01768260
Study type	Interventional
Source	First Affiliated Hospital, Sun Yat-Sen University
Contact	Yan Zhang, MD
Phone	862087755766
Email	Zhyan3@mail.sysu.edu.cn
Status	Recruiting
Phase	N/A
Start date	December 2012
Completion date	March 2018

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05749094` - Optic Nerve Sheath Ultrasound in Giant Cell Arteritis
Withdrawn	`NCT01607671` - Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5%	Phase 1
Completed	`NCT03401892` - Retinal Neuro-vascular Coupling in Patients With Non-arteritic Anterior Ischemic Optic Neuropathy	N/A
Terminated	`NCT00867815` - PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)	Phase 4
Completed	`NCT01260324` - Epidemiology Study of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)